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Fucoxanthin: Overview and Sources
Fucoxanthin is a light‐harvesting carotenoid pigment that occurs in the
chloroplasts of the eukaryotic Chromalveolata (phylum Heterokontophyta, class
Ochrophyta), including brown macroalgae (Phaeophyceae), and in unicellular
microalgae, such as diatoms (Bacillariophyceae) (Cavalier‐ Smith and Chao

2006). Fucoxanthin is estimated to account for more than 10% of the total
production of carotenoids in nature, and is responsible for the brown to yellow
colour of brown macroalgae (seaweeds) and diatoms, where it masks green
chlorophyll a and c (Hurd et al. 2014; Peng et al. 2011). Fucoxanthin was first
isolated in Germany in 1914 from the brown seaweeds, Dictyota, Fucus, and
Laminaria (Willstätter and Page 1914). Industrially, Japanese wakame (Undaria
pinnatifida) is the seaweed most widely utilised for fucoxanthin extraction due to
high concentrations of the pigment (≥10%) in the lipid extract (Billakanti et al.
2013). Other marine macroalgae known to contain fucoxanthin include the
genera

Ascophyllum,

Fucus,

Laminaria,

Pelvetia,

Ecklonia,

Eisenia,

Himanthalia, Sargassum, Saccharina, Ectocarpus, Schytosiphon, Petalonia,
Carpophyllum, Hizikia, Padina, Dictyota, Myagropsis, Turbinaria, Cladosiphon,
and Cystophora (Dominguez 2013; Haugan and Liaaen‐ Jensen 1994; Heo et
al. 2010; Jaswir et al. 2011; Kanazawa et al. 2008; Mikami and Hosokawa
2013; Mise et al. 2011; Miyashita and Hosokawa 2007; Sangeetha et al. 2010;
Shang et al. 2011; Yan et al. 1999).
Notable fucoxanthin‐containing microalgae include the diatoms Odontella aurita,
Phaeodactylum tricornutum, Chaetoceros gracilis, Thalassiosira weissflogii, and
Cyclotella meneghiniana; the Prymnesiophyceae species Emiliania huxleyi,
Pavlova lutheri, and Phaeocystis pouchetii; and the Chrysophyceae species
Pelagococcus subviridis (di Valentin et al. 2013; Pyszniak and Gibbs 1992;
United States Department of Agriculture 2015; Wright and Jeffrey 1987; Xia et
al. 2013). These microscopic algae occur as marine plankton.

Globally, Japan, Korea, and China have the greatest seaweed production,
consumption, and most developed fucoxanthin extraction industry (Ryan 2014).
Irish coastlines also support the growth of fucoxanthin‐containing brown
seaweeds, such as bladderwrack (Fucus vesiculosus), channelled wrack
(Pelvetia canaliculata), knotted wrack (Ascophyllum nodosum), oarweed
(Laminaria

digitata),

sea

rod

(Laminaria

hyperborea),

sea

spaghetti

(Himanthalia elongata), serrated wrack (Fucus serratus), and sugar kelp
(Saccharina latissima; formerly Laminaria saccharina) (Dominguez, 2013;
Morrissey et al. 2001; Stengel and Dring 1998).

Chemistry of Fucoxanthin
Carotenoids are tetraterpene pigments which occur in plants, algae, and
photosynthetic bacteria. Carotenoids composed entirely of hydrogen and
carbon belong to the subclass of carotenes, while those that additionally contain
oxygen are classed as xanthophylls. Fucoxanthin is a xanthophyll, similar to the
plant xanthophylls violaxanthin, neoxanthin, and lutein (Kotake‐Nara and Nagao
2011). Xanthophylls share some chemical and physical properties with
carotenes, such as lipophilicity and antioxidant activity due to their ability to
quench reactive oxygen and nitrogen species (Kim and Chojnacka 2015).
However, the presence of oxygen in the hydroxyl and epoxide groups of
xanthophylls makes them more polar than carotenes (Landrum 2009).
Fucoxanthin’s systematic name is (3S,3′S,5R,5′R,6S,6′R,8′R)‐3,5′‐ dihydroxy‐8‐
oxo‐6′,7′‐didehydro‐5,5′,6,6′,7,8‐hexahydro‐5,6‐ epoxy‐β,β‐caroten‐3′‐yl acetate.

It contains an allelic bond, an epoxy group, and six oxygen atoms, as shown in
Figure 3.1 (Chemspider 2015).

Figure 3.1 Fucoxanthin molecular structure (formula C42H58O6).

In industry, it is most commonly extracted with solvents such as n‐hexane,
methanol, DMSO, ethanol, petroleum ether, diethyl ether, dimethyl ether,
acetone, or ethyl acetate, and dried to a powder (Kanda et al. 2014; Kim
2011b).
In algal cells, fucoxanthin is contained in the chloroplasts, within membrane‐
bound compartments called thylakoids. In the thylakoids, fucoxanthin binds with
chlorophyll a, c, and apoproteins, forming complexes that absorb light in the
blue‐green region of the spectrum and transfer energy to the alga. At depths of
several meters, this is commonly the only spectral wavelength available to
marine algae (Kita et al. 2015). Fucoxanthin captures a broader spectrum of
light (449–540nm) than chlorophyll a and c alone, which increases the efficiency
of photosynthesis (Kim et al. 2011; Pyszniak and Gibbs 1992). It also protects
the algal cells from damage by reactive oxygen species caused by constant
exposure to high levels of oxygen and light in the ocean. Fucoxanthin generally

occurs more significantly in the blade of the seaweed thallus, which experiences
the greatest light exposure, compared to the stipe and holdfast (Lobban and
Wynne 1981).
Fucoxanthin can exist in a trans or cis configuration. The trans isomer is the
more chemically stable and potent antioxidant of the two, and comprises ~90%
of the fucoxanthin found in nature (Holdt and Kraan 2011; Nakazawa et al.
2009). Fucoxanthin content varies widely amongst macro‐ and microalgae. For
example, the brown seaweed Fucus serratus has been reported to contain 0.56
mg/g (dry weight, DW) (Haugan and Liaaen‐Jensen 1994) compared to 2.67
mg/g in Undaria pinnatifida (DW) (Mori et al. 2004). Most diatoms and other
microalgae have a greater fucoxanthin content than brown seaweeds (Kawee‐ai
et al. 2013), but are less commonly used commercially for extraction due to the
necessity for photobioreactors and strict culturing conditions. Xia et al. (2013)
reported the fucoxanthin content in eight species of diatoms, ranging from 2.24
mg/g (DW) in Chaetoceros gracilis to 18.47 mg/g (DW) in Odontella aurita.
Seasonal and geographic variations hugely affect content. For example, brown
seaweeds harvested from September to March, during the mature phase of the
sporophyte, commonly contain higher concentrations of fucoxanthin (Fung et al.
2013; Terasaki et al. 2009). This has been attributed to the upregulation of the
xanthophyll, or violaxanthin, cycle pathway in reduced levels of sunlight during
the winter. Under environmental stressors such as reduced light exposure, the
formation of fucoxanthin from zeaxanthin via the epoxidation of antheraxanthin,
violaxanthin,

and

diadionoxanthin

may

be

accelerated

to

regulate

photosynthetic pathways (Campbell et al. 1999; Goss and Jacob 2010; Mikami
and Hosokawa 2013; Ramus et al. 1977).

Current Applications
Despite its discovery and isolation in seaweed over one hundred years ago,
fucoxanthin has remained somewhat underutilised in food and pharmaceutical
applications. Initial studies focused on quantification and extraction methods,
structural elucidation, and biosynthetic pathways. It was not until the late 1990s
that scientific papers began to emerge on fucoxanthin’s potential as a functional
food. This was most probably due to growing clinical evidence at the time of the
role of antioxidants in the prevention of chronic diseases. Currently, fucoxanthin
is available to retail consumers in the form of relatively expensive weight loss
supplements, of varying purity and quality, from health stores and online. Unlike
other carotenoids, such as β‐carotene, which are commonly used as food
colourants, 100% pure fucoxanthin is not sold as a bulk food ingredient (Hurst
2002). Its instability due to oxidation and high extraction costs have, to date,
been prohibitive. Currently, fucoxanthin is available to food producers as a
percentage of various seaweed extracts. Analytical grade fucoxanthin (≥ 95%
pure) is produced for laboratories, but retails at €556 per 50 mg (Sigma‐Aldrich
2015a).

Food and Pharmaceutical Regulations
In 2009, the European Food Safety Authority (EFSA) published its scientific
opinion on fucoxanthin and the substantiation of health claims related to it and

maintenance or achievement of a normal body weight, in the case of Undaria
pinnatifida thallus extract, under Article 13(1) of Regulation (EC) No 1924/2006.
It determined that the extract, as a food constituent, had been sufficiently
characterised to be consumed in an amount equivalent to 15 mg pure
fucoxanthin per day. However, to date, the EFSA has not accepted that a
relationship has been established between its consumption and the
maintenance or achievement of a normal body weight (European Food Safety
Authority 2009). Other health claims, such as antidiabetic or anticancer effects,
relating to fucoxanthin have not yet been evaluated by the EFSA. In the
Republic of Ireland, the Health Products Regulatory Authority does not list
fucoxanthin as a controlled substance, or include it in the List of Medicinal
Herbs considered acceptable as THMPs, under the European Traditional
Herbal Medicinal Products Directive (2004/24/EC) which came into effect in
Ireland in 2007 (Health Products Regulatory Authority 2015).
The clinical evidence supporting fucoxanthin’s health benefits has not yet been
evaluated by the US Food and Drug Administration. However, fucoxanthin can
be sold in the United States as a food supplement with the disclaimer “These
statements have not been evaluated by the Food and Drug Administration. This
product is not intended to diagnose, treat, cure, or prevent any disease” on the
product label (US Food and Drug Administration 2014). In Japan, Food for
Specified Health Uses (FOSHU) under the Ministry of Health, Labour and
Welfare have not evaluated fucoxanthin as a functional food ingredient or
pharmaceutical; however, it can be sold as a food supplement.

Applications in Human Health
Although fucoxanthin has not been evaluated by some food regulatory bodies,
in recent years it has been studied clinically for its antioxidant properties, which
inhibit free radical damage in cells, reducing the risk of many chronic diseases.
It has also been studied for its anticancer, anti-type 2 diabetes, antiobesity,
anticholesterol,

anti-inflammatory,

antiangiogenic,

antimalarial,

and

antihypertensive activities, and for the treatment of Alzheimer’s disease
(Gammone and d’Orazio 2015; Hosokawa et al. 1999; Ikeda et al. 2003;
Kawee‐ai et al. 2013; Kim 2011a; Kotake‐Nara et al. 2001; Maeda et al. 2007;
Rodrigues et al. 2012; Shiratori et al. 2005; Sivagnanam et al. 2015).

Antiobesity Effects
Obesity, type 2 diabetes, metabolic syndrome, and chronic inflammatory
diseases are global health epidemics. The World Health Organization estimates
that, globally, 2.3 billion people will be overweight and 700 million obese by
2015. To prevent and treat diseases such as these, natural, bioactive, functional
compounds such as fucoxanthin are increasingly being studied as an alternative
to, or as combination therapy with, orthodox medicines (Peng et al. 2011;
Watson, 2014).
In obesity treatment, fucoxanthin has been shown to mediate the induction of
uncoupling protein‐1 (UCP‐1) in abdominal adipose tissue mitochondria in
murine studies, leading to the oxidation of fatty acids and heat production,
resulting in a reduction in white adipose tissue (d’Orazio et al. 2012; Maeda et
al. 2005). Abidov et al. (2010) conducted a double‐blind placebo‐controlled

study of 115 non‐ diabetic, obese, premenopausal women with a liver fat
content above 11% at the Russian Academy of Medical Sciences. A daily
supplement of 300 mg brown seaweed extract (species not specified)
containing 2.4 mg fucoxanthin, combined with 300 mg pomegranate seed oil,
was administered. An olive oil capsule was administered to the placebo group.
The treatment group showed a significant increase in resting energy
expenditure and mean weight loss of 4.9 kg after 16 weeks. In Japan, a kombu
(Saccharina japonica) extract of fucoxanthin (3%) was evaluated for its
antimetabolic syndrome effects in human clinical trials. A daily dosage of the
extract, equivalent to 0.5–1.0 mg pure fucoxanthin/ day, was found to have a
significant effect on blood serum parameters related to metabolic syndrome
(Oryza 2015). However, no official RDA for fucoxanthin has been established by
the World Health Organization.
Topical preparations as vehicles for fucoxanthin in the treatment of obesity have
also been reported. Dai et al. (2014) developed a stable microemulsion
containing 0.25% pure fucoxanthin using medium chain triglyceride as the oil
phase, Tween 80 as a surfactant, and polyethylene glycol 400 as a co‐
surfactant.

Anticancer Effects
Fucoxanthin’s anticancer activity is hypothesised to be due to its ability to
induce apoptosis in tumour cells (Nakazawa et al. 2009). Hosokawa et al.
(1999) found that fucoxanthin induced apoptosis in human promyelocytic
leukaemia HL‐60 cells by cleaving procaspase‐3 and poly‐ADP‐ribose

polymerase. Kim et al. (2010) showed that fucoxanthin induced reactive oxygen
species generation, inactivated the Bcl‐xL signalling pathway, and induced
caspase‐3, ‐7, and poly‐ADP‐ribose polymerase cleavage, triggering the
apoptosis of HL‐60 cells, indicating that the generation of reactive oxygen
species was a critical target in fucoxanthin‐ induced apoptosis of these cells.
Wang et al. (2014) reported significant growth inhibition of cells in nine human
cancer cell lines with extracts of Undaria pinnatifida containing fucoxanthin.
Satomi and Nishino (2013) reported fucoxanthin extract to have a significant
effect on the expression and enzymatic activity of the xenobiotic metabolising
enzymes CYP1A1, CYP1A2 and CYP3A4, which are involved in the activation
of pro‐carcinogens. The study found that the inhibitory effect of fucoxanthin (≤
45μM) on these enzymes in human hepatocellular carcinoma HepG2 cells and
recombinant human CYPs could also attenuate the action of some anticancer
drugs that are normally activated by CYP3A4.

Antidiabetic Effects
Fucoxanthin’s antidiabetic activity has been studied in mice with induced type 2
diabetes. It has been found to improve insulin resistance and decrease blood
glucose levels mainly via the regulation of cytokine secretions from white
adipose tissue (Miyashita et al. 2011). Other studies found that a fucoxanthin‐
enriched diet promoted the recovery of blood glucose uptake to muscle by the
upregulation of GLUT4 mRNA expression. Fucoxanthin has also been shown to
affect the peroxisome proliferator‐activated receptor γ (PPARγ) and promote
gene expression related to lipid metabolism in adipocytes. In cultivated cells,
fucoxanthin prevented inflammation and insulin resistance by inhibiting nitric

oxide and PGE2 production through the down-regulation of iNOS and COX‐2
mRNA expression, as well as adipocytokine production in white adipose tissue
(Hosokawa et al. 2010; Maeda et al. 2006; Miyashita et al. 2011).

Dietary Antioxidant Effects
The antioxidant capacity of seaweed s has been widely reported (Heffernan et
al. 2014). As a dietary antioxidant, fucoxanthin has been shown to improve the
antioxidant capacity of blood serum levels in mammals. Fucoxanthin is unusual
in that it donates an electron to reactive oxygen species, instead of a proton
(hydrogen), as most antioxidants such as ascorbic acid or β‐carotene do.
Fucoxanthin can also quench reactive oxygen species under hypoxic
physiological conditions, unlike the majority of food‐derived antioxidants
(Nomura et al. 1997; Yan et al. 1999). A high‐fat diet has been associated with
obesity in humans and other mammals, and has been shown to cause
overproduction of reactive oxygen species (Dandona et al. 2005). Reactive
oxygen species are known to cause cellular damage, which is implicated in the
pathogenesis of diseases such as type 2 diabetes, cardiovascular disease,
cancer, and infectious illnesses (Uzun et al. 2004). Ha et al. (2013) reported
that fucoxanthin supplementation improved the antioxidant capacity of blood
serum levels in obese rats via activation of the nuclear erythroid factor like‐2
pathway and its downstream target gene NQO1. A study by Zaragozá et al.
(2008) on the antioxidant effect of fucoxanthin extract from Fucus vesiculosus
found that the extract exhibited increased antioxidant activity in ex vivo assays
of erythrocytes and plasma, after 4 weeks of daily oral administration in rats.
Significant antioxidant activity was also observed in non‐cellular systems and in

activated RAW 264.7 mouse leukemic monocyte macrophage cell lines.
Therefore, supplementation of fucoxanthin may also reduce the risk of oxidative
stress in humans.
Fucoxanthin has also been successfully used topically to protect against UV‐B‐
induced cell damage in hairless mice, and in human fibroblast cell lines as an
antioxidant against skin aging caused by free radical damage (Heo and Jeon
2009; Urikura et al. 2011).

Toxicity Studies
No toxicity of fucoxanthin extracts has been reported to date, making it a good
candidate for functional food use. A number of clinical trials in animal models
have shown no significant toxicity with short‐ or long‐term dosage. For example,
in Japan, a recently developed functional food ingredient, containing up to 5%
fucoxanthin from kombu (Saccharina japonica) extract, was evaluated on rats.
Toxicity and micronucleus tests were conducted. No toxicity or abnormalities
were found after 14 or 90 days. The LD50 of the extract (3.0% fucoxanthin) was
calculated to be 2000 mg/kg body mass for rats (Oryza 2015). Maeda et al.
(2005) supplemented a murine diet with 0.27% fucoxanthin, equivalent to ~0.25
mg/kg body mass per day for 4 weeks, and found no side effects or
abnormalities. Kadekaru et al. (2008) conducted a toxicity study on the repeated
oral dosing of fucoxanthin (95% purity) to rats for 28 days, and found that it
showed no apparent toxicity. Zaragozá et al. (2008) found no ill effects following
a 4‐week, acute toxicity test in rats, where a daily treatment of 0.0012% pure
fucoxanthin extract from Fucus vesiculosus was administered. A single dose

toxicity study (Beppu et al. 2009) was conducted with doses of 1000 and 2000
mg/kg body mass and a repeated oral dose toxicity study with doses of 500 and
1000 mg/kg for 30 days on purified fucoxanthin (93% purity) in ICR mice. No
mortality, abnormalities, abnormal changes in liver, kidney, spleen, or gonadal
tissues were found in either study.
Human toxicity studies are required to assess both the toxicity levels and daily
dosage for efficacy against any of the disorders discussed above.

Fucoxanthin as a Functional Food: Challenges and
Opportunities
Fucoxanthin faces chemical, organoleptic, and bioavailability challenges as a
functional food ingredient. Due to its chemical structure, fucoxanthin in its pure
form is easily oxidised by high temperatures, low or high pH, UV light, and long
storage periods (Kawee‐ai et al. 2013; Mise et al. 2011). This may lead to
chemical or enzymatic interactions with other ingredients over time.
Organoleptic attributes, such as texture, taste, appearance, or smell, may
deteriorate as a result of these interactions. Sensitivity to heat poses a problem
for bakery products or sauces that require boiling, and foods that contain fruit or
probiotic cultures may be too acidic. The natural brown colour, savoury flavour,
and powdery texture of fucoxanthin itself may also make it unsuitable for some
food products. The idea of eating seaweed derivatives may be unpalatable to
some consumers, even at undetectable levels. This may be encountered in
Western cultures where seaweed is rarely part of the diet, and misconceptions
of a potential “fishy” or “sea” taste could arise.

Like other non‐polar pigments, such as chlorophyll and lycopene, fucoxanthin is
insoluble in water. Incorporation into water‐based beverages or sauces would
require emulsification or dispersion in appropriate colloids (Socaciu 2007). The
lipid‐soluble nature of fucoxanthin also affects its bioavailability in mammals
(Sangeetha et al. 2010). Fucoxanthin is metabolised in the intestine into
fucoxanthinol

by cholesterol

esterase

and

lipase,

then

converted

to

amarouciaxanthin A in the liver (Bagchi and Preuss 2012; Dominguez, 2013).
The presence of some form of dietary lipid is required when fucoxanthin is
consumed for solubility and absorption (Peng et al. 2011). Another
consideration for fucoxanthin as a functional food is the high cost, due to the
energy required for the extraction and freeze‐drying process (Billakanti et al.
2013) and the lack of an artificial synthesis method for fucoxanthin. Seasonal
variations in fucoxanthin nutritional content (Fung et al. 2013) could also affect
health claims and nutritional efficacy.
Despite these potential hurdles, fucoxanthin has several intrinsic, beneficial
properties. Fucoxanthin, along with other carotenoids such as astaxanthin, is a
more powerful antioxidant than many other natural and synthetic antioxidants
(Miyashita and Hosokawa 2007). Using chemiluminescence detection, Nishida
et al. (2007) reported that fucoxanthin had stronger singlet oxygen‐quenching
activities

than

ascorbic

acid,

α‐tocopherol,

quercetin,

resveratrol,

(‐)‐

epigallocatechingallate, lutein, lycopene, gallic acid, pyrocatechol, α‐lipoic acid,
and the synthetic antioxidant butylated hydroxytoluene. Consumer awareness
and interest in naturally antioxidant‐rich foods have grown in recent years (Kim
2013; Rodrigues et al. 2012). Seaweed extracts such as carrageenan, alginate,

and other hydrocolloids are already accepted by consumers as widely used
ingredients in the food, pharmaceutical, and cosmetic industries (Venugopal
2011). Marine‐derived functional foods such as fucoxanthin have the potential
to be marketed as a more potent and sustainable alternative to many natural
and synthetic antioxidants, particularly in countries such as Japan, China, and
Korea, where seaweed is a common part of the diet. Fucoxanthin is also
Kosher, Halal, and suitable for vegetarians and vegans.
As discussed later in this chapter, little has been reported in peer‐ reviewed
journals regarding the use of fucoxanthin as a functional ingredient. Most
fucoxanthin research has focused on medical rather than functional food
applications. However, a study conducted by Prabhasankar et al. (2009) at the
Central Food Technological Research Institute, Mysore, in India reported the
successful addition of fucoxanthin and fucosterol as a constituent of wakame
(Undaria pinnatifida) powder extract into semolina (wheat)‐based pasta.
Fucosterol is a structural component of algal lipid membranes which has been
shown to have antioxidant, anticancer, antidiabetic, and hepatoprotective
properties in animal trials (Alasalvar et al. 2011; Jung et al. 2013; Lee et al.
2003). Prabhasankar et al. (2009) investigated the effect of different percentage
additions of wakame powder on the sensory, cooking, nutritional, and
biofunctional quality of pasta. Blends of semolina and seaweed were combined
by replacement method in ratios of (semolina/wakame, w/w) 100:0, 95:5.0,
90:10, 80:20, and 70:30. In sensory analysis of taste, mouth‐feel, appearance,
and strand quality, 15 semi‐trained panellists, who were regular consumers of
wakame, found no significant (P>0.05) or discernible organoleptic differences

between the control and the wakame pasta up to 10% total ingredient mass,
with acceptance decreasing after 10% up to 20% wakame content. Above 20%,
panellists reported saltiness and a seaweed taste. Since wakame is composed
of other components such as polysaccharides, proteins, lipids, and minerals,
10% wakame, in this study, equated to 0.04 mg/g (DW) of fucoxanthin and 1.25
mg/g (DW) of fucosterol of the dry ingredient portion. HPLC analysis of the
pasta after processing/ kneading, and after cooking (25g of raw pasta in 250mL
boiling water for 8 min) showed a loss of less than 10% for both fucoxanthin and
fucosterol. The authors hypothesised that this remarkable preservation occurred
due to stability of fucoxanthin/fucosterol in the protein matrix of gluten. To the
authors’ knowledge, the stability of fucoxanthin in a food system has not been
reported in any other studies. To date, these lab‐scale pilots have not been
reported as developed to commercial scale.
A recent Irish study reported the successful incorporation of ethanol and water
extracts of Fucus vesiculosus and Ascophyllum nodosum, at 0.25% and 0.50%,
into yoghurt and fluid milk (O’Sullivan 2013). The fucoxanthin content of the
seaweed extracts was not reported. However, it is probable that both contained
fucoxanthin, due to its presence being widely reported in both species and their
extracts (Stengel and Dring 1998; Zaragozá et al. 2008). Sensory analysis
found that overall acceptability of the yoghurts was governed by appearance
and flavour, with the 100% water extract of A. nodosum having the greatest
panel preference and least yellowness. Overall acceptability of the milk was
governed by perception of a fishy flavour. Again, the 100% water extract of A.
nodosum (0.50% addition) was found to be the most acceptable in terms of

taste, and the least green/yellow. In vitro antioxidant analysis found no
deterioration of antioxidant activity, shelf‐life, or pH in the seaweed‐
supplemented milk and yoghurt formulations.
Fucoxanthin, like many natural food extracts, is widely available wholesale
online from many companies, primarily based in China. It is sold in the form of
dried seaweed extract, generally from wakame or kombu, with stated
percentages of fucoxanthin purity ranging from 10% to 98%. Price ranges
widely, from less than $1 to $2000 per gram, as do claims of purity and
certification (Alibaba 2015; Kyndt and d’Silva 2013).
However, in Japan, a government‐certified functional food ingredient has
recently been commercially developed from kombu (Saccharina japonica)
containing 1–5% fucoxanthin. The powder and oil products contain only
cyclodextrin, or triglyceride, in addition to the kombu extract, and natural
tocopherol. Stability testing of the products found the fucoxanthin fraction to be
thermostable up to 80 °C for 1 hour, and stable in solution from pH 3.0 to 10.0,
with the greatest loss being 6% after 1 week at pH 3.0. The addition of the
antioxidant preservative tocopherol to the products is most likely the stabilising
factor in this case. The triglyceride and cyclodextrin may also offer a protective
matrix for the fucoxanthin, combined with photo‐protective, vacuum packaging.
The powder and oil products were reported to have been successfully
incorporated into beverages, cakes, shortbread, puffed rice biscuits, spreads,
and potato snacks. However, the percentage of fucoxanthin extract used was
not specified, nor have any sensory evaluation results been published to date
(Oryza 2015).

Outside Asia, in the USA, a project was initiated in 2010 by the Research,
Education, and Economics Information System of the Department of Agriculture
and the National Institute of Food and Agriculture, Auburn University, Alabama,
to optimise large‐scale fucoxanthin extraction from the diatom Chaetoceros
gracilis. The effects of the extracts on energy balance in an animal model of
obesity are being used to develop a functional food for the public health
treatment of obesity to reduce the risk of developing cardiovascular disease,
type 2 diabetes, and some forms of cancer. The project intends the functional
food industry to be the immediate beneficiary of the study, but also aims to
target the wider food industry, nutritionists, scientists, and engineers (United
States Department of Agriculture 2015). There have been no publications from
the project to date.
This significant project, in the country with the highest global rates of obesity,
along with the success of the pasta study and Japan’s government‐sponsored
development of stable oil‐ and water‐soluble fucoxanthin products, is very
encouraging for further exploration of fucoxanthin as a functional food ingredient
on a large commercial scale.

Approaches

to Overcome

Adverse

Reactions

in Functional Food Models
Micro and Nanoencapsulation
The principal obstacles to the incorporation of fucoxanthin in a food or beverage
matrix are water insolubility, pH instability, sensitivity to oxidation, and impaired

bioavailability. These properties are an issue with existing food ingredients,
such as other carotenoids and polyphenolic compounds, but can be overcome
with various technologies and approaches. Microemulsions composed of a
water phase, lipid phase, and an amphiphilic compound are widely used to
combine lipid solutes, such as carotenoids, into a hydrophilic matrix for food and
pharmaceutical purposes (de Campos et al. 2012).
Indrawati et al. (2015) encapsulated an acetone extract (primarily trans
fucoxanthin) of Indonesian Sargassum species in maltodextrin and Tween 80
(~70:1). The Sargassum extract was combined with canola oil and
homogenised in the water‐based maltodextrin/Tween 80 emulsion. After freeze
drying, the fucoxanthin was found to be stable within the microencapsulates for
63 days at 28°C under inert atmosphere. Encapsulating fucoxanthin in this
manner increases its suitability for incorporation into dried food products.
Suhendra et al. (2012) succeeded in formulating a clear, stable, oil‐in‐water
microemulsion for fucoxanthin, capable of delivering this hydrophobic
antioxidant in aqueous food systems. Virgin coconut oil was used as the lipid
phase with a combination of Tween 20, Tween 80, and Span 80 as non‐ionic
surfactants. The ratios were oil:surfactants (3:17); oil + surfactants:water
(35:65); Tween 80:Tween 20:Span 80 (92.0:2.5:5.5). The microemulsion
remained stable after exposure to pH 3.5–6.5, 105 °C for 5 hours, and
centrifugation at 4500rpm for 30 minutes. Quan et al. (2013) reported a water‐
soluble fucoxanthin food application using fucoxanthin‐loaded microspheres,
composed of a gum arabic/fish gelatin coacervate shell cross‐linked by tannic
acid, with a solid lipid core of acetyl palmitate and canola oil. Wet and freeze‐

dried forms of the solid lipid core microspheres were developed successfully.
Stability of encapsulated fucoxanthin during long‐term storage was significantly
increased,

as

was

sustained

release

in

a

simulated

gastrointestinal

environment.
Nanogels have been used extensively in the pharmaceutical industry to protect
acid‐labile bioactive compounds from the acidic stomach environment before
reaching the intestinal tract (Liechty et al. 2010; McClements et al. 2009a). This
technology easily translates to functional food delivery. For example, the
biological availability and stability of fucoxanthin were reported to have
significantly

increased

after

encapsulation

with

chitosan‐sodium‐

tripolyphosphate‐glycolipid nanogels, prepared by ionic gelation (Ravi and
Baskaran 2015). The authors were inspired by a study (Gorusupudi and
Baskaran 2013) reporting the improved bioavailability of a similar compound,
lutein, in mice, by solubilising the extract first in the glycolipid fraction of wheat
germ oil. Apart from protecting the core material (fucoxanthin) against
degradation,

encapsulation

prevents

reactions

with

other

ingredients

(McClements et al. 2009b), and any seaweed flavour or brown colour is
prevented from leaching into the food.

Current Trends in Fucoxanthin Research
Most extraction methods currently practiced are based on the utilisation of
organic acids and solvents to break down the cell walls of seaweed
or microalgae. Current trends are leaning towards greener chemical or physical
extraction methods.

Green Extraction Technologies
Pressurised Liquid Extraction
Shang et al. (2011) utilised pressurised liquid extraction with ethanol to optimise
fucoxanthin yields from the seaweed Eisenia bicyclis. A yield of 0.39 mg/g was
achieved with 90% ethanol, 110°C, 1500 psi, for 5 minutes of extraction static
time. This was close to the predicted statistical experimental yield of 0.42 mg/g.
Supercritical Carbon Dioxide Extraction Supercritical carbon dioxide extraction
is another green chemical method with potential for commercial seaweed
applications. Sivagnanam et al. (2015) extracted fucoxanthin from the brown
seaweeds Sargassum horneri and Saccharina japonica using supercritical CO2
with ethanol as a co‐solvent (SC‐CO2E) for 2 hours at 45 °C in a semi‐batch
flow extraction process. SC‐CO2E extraction yield of fucoxanthin from S. horneri
was 0.77 mg/g, compared to only 0.71 mg/g from traditional acetone‐ methanol
extraction. SC‐CO2E extraction fucoxanthin yield from S. japonica was 0.41
mg/g, close to the acetone‐methanol extraction yield of 0.48 mg/g. An in vitro
hydrogen peroxide scavenging antioxidant activity assay showed the SC‐CO2E
fucoxanthin extracts from S. horneri and S. japonica had significantly greater
activity, or maximal inhibitory concentration (IC50 value), than acetone‐
methanol, hexane, or ethanol extracts. The IC50 values of the SC‐CO2E
extracted S. horneri fucoxanthin (686 µg/mL) and S. japonica (600 µg/mL) were
significantly greater than that of an ascorbic acid standard (448 µg/mL). SC‐
CO2E fucoxanthin extracts from both species were also found to exert

angiotensin I‐converting enzyme inhibitory effects in vitro comparable with those
of the acetone‐methanol extract.
Quitain et al. (2013) used supercritical carbon dioxide extraction with Undaria
pinnatifida, combined with a microwave pre-treatment, to disrupt the cell
membrane. Yields equivalent to 80% of those obtained with traditional solvent‐
based methods were reported using 40MPa, for 180 minutes, at 40 °C, without
producing any chemical waste. Roh et al. (2008) extracted fucoxanthin and
polyphenols from Undaria pinnatifida using supercritical carbon dioxide, with
ethanol as a co‐solvent. However, fucoxanthin yields were significantly lower
than those obtained with solvent extracts, ranging from 0.00048 to 0.00753
µg/g. Optimum supercritical extraction was achieved after 50 minutes with a
flow rate of 28.17 g CO2/min, 2 mL/min ethanol, at a pressure of 200 bar, and a
temperature of 323 K (49.85°C). Subramanian et al. (2013) optimised a novel,
ultrasound‐assisted extraction method, using Sargassum muticum. Fucoxanthin
yields of 0.613 mg/g were reported with optimum parameters of 70% ethanol, at
80 °C, for 10 minutes, at an amplitude of 78 W, with a solid to solvent ratio of
1:5 w/v g/mL.

Microwave-Assisted Extraction
Xiao et al. (2012) developed a rapid (75 minute) microwave‐assisted extraction
method combined with high‐speed counter‐current chromatography, with a two‐
phase solvent system of hexane‐ethyl acetate‐ethanol‐water (5:5:6:4, v/v/v/v).
Fucoxanthin yields close to those of traditional methods were obtained from
Saccharina japonica (0.83 mg/g), Undaria pinnatifida (1.09 mg), and Sargassum

fusiforme (0.20 mg/g). HPLC showed the extracts to have a minimum purity of
90%.

Enzymatic Extraction
Fucoxanthin extraction through the application of targeted enzymes, such as
cellulases, has the potential to increase yield and safety. The presence of
branched, sulphated, or complex polysaccharides, such as alginate and
laminarin, in algal cell walls limits the efficiency of classic extraction methods
(Kim 2011c; Kim and Chojnacka 2015). Enzymolysis, i.e., the hydrolysis (of cell
wall polysaccharides) with enzymes, should, in theory, aid in degradation of the
wall and release of the pigment‐containing chloroplasts within. Enzyme‐assisted
extraction has already been used successfully to increase carotenoid yields
from terrestrial plants, such as lycopene from tomatoes. Zuorroa et al. (2011)
reported an 8 to18‐fold increase in lycopene yield from tomato processing
waste (skins) in pectinase and cellulase pre-treated samples, compared to
hexane extraction alone. Barzana et al. (2002) reported a similar result for the
extraction of carotenoids (primarily lutein) from marigold flowers. Typically, as
much as 50% of total carotenoid yield is lost in the traditional drying and hexane
extraction of marigold flowers. A pre-treatment of Pectinex, Viscozyme,
Neutrase, Corolase, and HT‐Proteolytic commercial enzymes was used to
significantly reduce the volume of hexane required, and completely eliminate
the drying and silage steps that cause degradation of the carotenoids.
Carotenoid yields of ≥85% were recovered from the marigold flowers in simple
stirring vessels. Barzana et al. (2002) hypothesised that if cost were no barrier,

the hexane could be omitted entirely, and enzymes alone, with the correct
parameters, would achieve the same yield.
In the extraction of algal bioactives such as antioxidants, polysaccharides,
carotenoids, and polyphenols, the use of enzymes has shown significant
potential as a viable alternative, or addition, to pure solvent methods (Je et al.
2009; Rhein‐Knudsen et al. 2015; Wijesinghe and Jeon 2012). Heo et al. (2005)
extracted water‐soluble antioxidant compounds from Sargassum, Ecklonia,
Ishige, and Schytosiphon genera using proteases (Neutrase, Protamex,
Alcalase, Flavourzyme, and Kojizyme) and carbohydrate‐ degrading enzymes
(Celluclast, Viscozyme, AMG, Ultraflo, and Termamyl). In vitro hydrogen
peroxide scavenging activity assays showed the majority of the enzyme extracts
had significantly greater activity than the commercial synthetic antioxidants α‐
tocopherol, butylated hydroxyanisole (BHA), and butylated hydroxytoluene
(BHT). For example, the hydrogen peroxide scavenging activity of Ultraflo‐
extracted Sargassum horneri was 92.69%, and Kojizyme‐extracted Ishige
okamurae 96.27%, compared to only 50.32% for BHT, 67.37% for BHA, and
64.11% for α‐tocopherol.
Ko et al. (2010) significantly increased the antioxidant activity of Sargassum
coreanum extracts using Celluclast and Neutrase commercial enzymes.
Celluclast is a cellulase derived from the fungus Trichoderma reesei which
hydrolyses (1,4)‐β‐D‐glucosidic linkages in cellulose and other β‐D‐glucans,
forming cellobiose glucose and other glucose polymers (Sigma‐Aldrich 2015b).
Neutrase is a metalloprotease derived from Bacillus amyloliquefaciens. Similar

to thermolysin, it hydrolyses proteins into peptides (Nagodawithana and Reed
2013). The S. coreanum Neutrase and Celluclast extracts had significantly
greater DPPH and hydrogen peroxide radical scavenging activities compared to
eight other proteases and cellulases studied. The S. coreanum extracts were
screened for cancer cell inhibition and found to suppress the growth of HL‐60
cells through apoptosis (Ko et al. 2012). Ahn et al. (2012) reported obtaining
antioxidant‐rich extracts from the chlorophyte (green alga) Enteromorpha
prolifera using the protease Protamex and the carbohydrase mix Viscozyme.
The extracts contained up to 8.4 mg/g total flavonoids and 4.5 mg/g total
polyphenols. Other E. prolifera extracts were produced using Flavourzyme, an
exopeptidase that hydrolyses N‐terminal peptide bonds, and Promozyme, a
pullulanase

(α‐dextrin

endo‐1,6‐α‐glucosidase)

derived

from

Bacillus

acidopullulyticus (Mehta et al. 2012). The Flavourzyme and Promozyme
extracts were found to have a significant angiotensin‐converting enzyme
inhibitory effect at concentrations of 1.0 mg/mL. No toxicity was exerted by any
of the enzyme‐assisted extracts in RAW264.7 cell cytotoxicity tests.
Little has been published on the use of enzymes for fucoxanthin extraction
specifically. Billakanti et al. (2013) reported a significant increase (9.3%) in
fucoxanthin extraction yields from wakame (Undaria pinnatifida) using alginate
lyase derived from Flavobacterium multivorum as a pre-processing step,
followed by dimethyl ether and ethanol extraction, compared to untreated preprocessing. Optimum enzyme pre-treatment parameters were found to be 37
°C, for 2 hours, at pH 6.2, 5% (w/v) solids, with 0.05 wt% enzyme using
continuous mixing. Centrifugation was used to separate hydrophilic hydrolysis

products from the residual seaweed biomass. Alginate lyase, also known as
mannuronate lyase, may have succeeded here where other enzymes have little
effect due to its ability to catalyse the hydrolysis of alginate in the cell wall into
smaller oligosaccharides, aiding extraction of fucoxanthin from the chloroplasts.
Alginate lyase cleaves β‐(1‐4)‐D‐mannuronic bonds to yield oligosaccharides
with 4‐deoxy‐α‐L‐erythro‐hex‐4‐enopyranuronosyl groups at the non‐reducing
terminus (Sigma‐Aldrich 2015b). Enzymes such as cellulose, protease or
pectinase cannot break the glycosidic bonds specific to the β‐D‐mannuronate in
alginate polysaccharides that occur in macroalgae (Sho et al. 2010).
Currently, this research institute (Dublin Institute of Technology, Ireland) is
screening a number of commercially available Irish seaweed species for their
fucoxanthin content, using novel extraction technologies. The species under
investigation include wild Atlantic wakame (Alaria esculenta), bladderwrack
(Fucus vesiculosus), channelled wrack (Pelvetia canaliculata), knotted wrack
(Ascophyllum nodosum), oarweed (Laminaria digitata), sea rod (Laminaria
hyperborea), sea spaghetti (Himanthalia elongata), serrated wrack (Fucus
serratus), furbellows (Saccorhiza polyschides), and sugar kelp (Saccharina
latissima).

Conclusion
Fucoxanthin is a bioactive compound found in one of the most prolific and
sustainable organisms on the planet, alga (Mohamed et al. 2012; Werner et al.
2004). Its efficacy and potential in terms of health applications have been widely
reported in clinical studies. However, further human clinical trials are necessary

to determine the safety and required daily dosage of fucoxanthin. Technical
modifications, such as encapsulation, and sensory trials must be undertaken
before fucoxanthin can be successfully utilised as a functional food ingredient.
Factors to consider include solubility in the food matrix, organoleptic effects,
stability, preservation against oxidation, consumer acceptability, bioavailability,
and toxicity risk. The current, prohibitive cost of fucoxanthin must also be
addressed. Possible solutions may include the development of more efficient
and greener extraction technologies, which require shorter extraction times and
less solvent, and have a more specific and higher extraction yield. The
sustainability of potential seaweed cultivars must be assessed before large‐
scale harvesting, to ensure the preservation of this precious marine resource.
© 2018 John Wiley & Sons Ltd. Published 2018 by John Wiley & Sons Ltd.
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